您的位置: 首页 > 农业专利 > 详情页

ANTICORPS MONOCLONAUX ANTI-CD40 ANTAGONISTES ET PROCEDES D'UTILISATION ASSOCIES
专利权人:
CHIRON CORPORATION
发明人:
LONG, LI,LUQMAN, MOHAMMAD,YABANNAVAR, ASHA,ZAROR, ISABEL,CHEN, BAO-LU,LU, XIAOFENG,LEE, SANG HOON,HURST, DEBORAH
申请号:
CA2544949
公开号:
CA2544949C
申请日:
2004.11.04
申请国别(地区):
CA
年份:
2014
代理人:
摘要:
Methods of therapy for treating diseases mediated by stimulation of CD40signaling on CD40-expressing cells are provided. The methods compriseadministering a therapeutically effective amount of an antagonist anti-CD40antibody or antigen-binding fragment thereof to a patient in need thereof. Theantagonist anti-CD40 antibody or antigen-binding fragment thereof is free ofsignificant agonist activity, but exhibits antagonist activity when theantibody binds a CD40 antigen on a human CD40-expressing cell. Antagonistactivity of the anti-CD40 antibody or antigen-binding fragment thereofbeneficially inhibits proliferation and/or differentiation of humanCD40~expressing cells, such as B cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充